Jazz Pharmaceuticals plc

NASDAQ:JAZZ

109.56 (USD) • At close September 18, 2024
Bedrijfsnaam Jazz Pharmaceuticals plc
Symbool JAZZ
Munteenheid USD
Prijs 109.565
Beurswaarde 6,766,022,228
Dividendpercentage 0%
52-weken bereik 99.06 - 137.39
Industrie Biotechnology
Sector Healthcare
CEO Mr. Bruce C. Cozadd
Website https://www.jazzpharma.com

An error occurred while fetching data.

Over Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in

Vergelijkbare Aandelen

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

9.16 USD

Bruker Corporation logo

Bruker Corporation

BRKR

66.8 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

69.21 USD

Repligen Corporation logo

Repligen Corporation

RGEN

142.03 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

26.71 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

119.85 USD

United Therapeutics Corporation logo

United Therapeutics Corporation

UTHR

342.59 USD

NovoCure Limited logo

NovoCure Limited

NVCR

17.61 USD

Masimo Corporation logo

Masimo Corporation

MASI

114.31 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)